Laura Ward
Gerontology · Reisterstown, MDNPI 1225646870
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,191, 2.4 times the $490 reported in 2023.
Across 141 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$468
- Pfizer$442
- AstraZeneca$343
- Novo Nordisk$284
- Exact Sciences$178
- Lilly USA, LLC$146
- plus $870 from 18 others
What the payments were for
- Food & beverage$2,731100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $468 |
| Pfizer | 23 | $442 |
| AstraZeneca | 18 | $343 |
| Novo Nordisk | 17 | $284 |
| Exact Sciences | 7 | $178 |
| Lilly USA, LLC | 9 | $146 |
| Astellas Pharma US Inc | 7 | $116 |
| Amgen(2 entities) | 5 | $97 |
| Bayer | 4 | $93 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Boehringer Ingelheim | 4 | $72 |
| Shield Therapeutics Inc | 2 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| GSK | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 2 | $46 |
| Dexcom, Inc. | 2 | $36 |
| Aerin Medical Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
How this compares
$2,731 in reported general payments places this provider in the 85th percentile of 108 gerontology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 18 | $29,820 |
| OzempicSemaglutide | 20 | $28,999 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $20,700 |
| JardianceEmpagliflozin | 22 | $16,452 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $6,096 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $5,999 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 109 | $3,360 |
| Bupropion XlBupropion Hcl | 49 | $1,950 |
| Montelukast Sodium | 127 | $1,862 |
| Rosuvastatin Calcium | 62 | $1,530 |
| Pantoprazole Sodium | 68 | $1,463 |
| Omeprazole | 73 | $1,458 |
| Atorvastatin Calcium | 158 | $1,440 |
| PaxlovidNirmatrelvir/Ritonavir | 12 | $1,429 |
| Metoprolol Succinate | 77 | $1,282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $442 | $31,24930 claims |
| Novo NordiskOzempic | $284 | $28,99920 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $57 | $26,79734 claims |
| Boehringer IngelheimJardiance | $72 | $16,45222 claims |
| AbbVieSynthroid | $468 | $43012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 108 gerontology providers in Maryland.
Other gerontology in Reisterstown
- Christi DieterichElkridge$15K
- Megan GessfordLeonardtown$12K
- Valdane RobinsonTowson$10K
- Victoria SinibaldiBaltimore$10K
- Angeline WilliamsCatonsville$6K
- Wingnay CherneskyParkville$5K
- Joyce LamWaldorf$4K
- Eyerusalem HagosEssex$4K
- Rebecca GrochowskiTowson$3K
- Diana NgOlney$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.